Ibuprofen 4% (w/v) Pivotal Bioequivalence Study

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

May 6, 2016

Study Completion Date

May 6, 2016

Conditions

Bioequivalence of the Test Formulation

Interventions

DRUG

Nurofen for Children®

Nurofen for Children® 400 mg/10 ml

DRUG

Algifor® Junior

Algifor® Junior 400 mg/20 ml

All Listed Sponsors

lead

Reckitt Benckiser Healthcare (UK) Limited

INDUSTRY

NCT03496324 - Ibuprofen 4% (w/v) Pivotal Bioequivalence Study | Biotech Hunter | Biotech Hunter